AU2003282069A1 - Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment - Google Patents

Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment

Info

Publication number
AU2003282069A1
AU2003282069A1 AU2003282069A AU2003282069A AU2003282069A1 AU 2003282069 A1 AU2003282069 A1 AU 2003282069A1 AU 2003282069 A AU2003282069 A AU 2003282069A AU 2003282069 A AU2003282069 A AU 2003282069A AU 2003282069 A1 AU2003282069 A1 AU 2003282069A1
Authority
AU
Australia
Prior art keywords
cancer
diagnosis
therapy
risk assessment
tumor marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003282069A
Other versions
AU2003282069A8 (en
Inventor
Thomas Buschmann
Marie-Laure Fogeron
Steffen Heim
Tatiana Ilyina
Stephanie Lamer
Jorn Meuer
Silvia Tortola Perez
Kirsten Rothmann-Cosic
Volker Seibert
Mark Van Der Linden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROPROTEOME AG
Original Assignee
EUROPROTEOME AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROPROTEOME AG filed Critical EUROPROTEOME AG
Publication of AU2003282069A1 publication Critical patent/AU2003282069A1/en
Publication of AU2003282069A8 publication Critical patent/AU2003282069A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
AU2003282069A 2002-11-01 2003-10-31 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment Abandoned AU2003282069A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02090365 2002-11-01
EP02090365.4 2002-11-01
PCT/EP2003/012162 WO2004040298A2 (en) 2002-11-01 2003-10-31 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment

Publications (2)

Publication Number Publication Date
AU2003282069A1 true AU2003282069A1 (en) 2004-05-25
AU2003282069A8 AU2003282069A8 (en) 2004-05-25

Family

ID=32187248

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282069A Abandoned AU2003282069A1 (en) 2002-11-01 2003-10-31 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment

Country Status (2)

Country Link
AU (1) AU2003282069A1 (en)
WO (1) WO2004040298A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20050881A1 (en) * 2005-05-16 2006-11-17 Anna Favre DIAGNOSTIC KIT FOR HIRSCHSPRUNG MEGALON CONGENITAL DISEASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001073030A2 (en) * 2000-03-28 2001-10-04 Diadexus, Inc. Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
DE10053047A1 (en) * 2000-10-13 2002-06-06 Univ Lausanne Epalinges Use of caveolin polypeptide or caveolin nucleic acid for treating cell proliferation-associated disorder e.g., cancer such as non-steroid dependent carcinoma, stomach carcinoma or colon carcinoma

Also Published As

Publication number Publication date
WO2004040298A3 (en) 2005-06-09
AU2003282069A8 (en) 2004-05-25
WO2004040298A2 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2003302892A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003225573A1 (en) Identification of ovarian cancer tumor markers and therapeutic targets
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
EP1515982A4 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003219555A1 (en) Depsipeptide for therapy of kidney cancer
AU2003217397A1 (en) Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2004104039A8 (en) Tumor antigens for prevention and/or treatment of cancer
AU6583700A (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002364501A1 (en) Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003245927A1 (en) Target genes for the diagnosis and treatment of cancer
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
AU2003250912A1 (en) Agents and methods for diagnosis and therapy of cancer and cancer risk assessment
AU2003230849A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003260301A1 (en) Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
AU2003282069A1 (en) Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment
AU2003293130A1 (en) Methods for identifying risk of breast cancer and treatments thereof
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003279312A1 (en) Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase